BIOPH CHINA 2026

BIOPH CHINA 2026: Shaping the Future of Biopharmaceutical Innovation
June 16–18, 2026 | Shanghai, China

BIOPH CHINA 2026, Asia’s premier biopharmaceutical summit, returns to Shanghai from June 16–18, 2026, uniting global industry leaders, researchers, and innovators to accelerate advancements in drug discovery, development, and commercialization. Hosted at the Shanghai World Expo Exhibition & Convention Center—a nexus of scientific and technological progress—the event will convene over 5,000 attendees, including executives from top biotech firms, academic pioneers, investors, and regulatory experts.

Core Focus Areas
The conference will spotlight cutting-edge themes critical to the biopharma landscape:
- Next-Generation Therapeutics: Deep dives into biologics, cell and gene therapies, mRNA technologies, and AI-driven drug design.
- Manufacturing Excellence: Discussions on continuous bioprocessing, quality by design (QbD), and sustainable production to meet global demand.
- Clinical & Regulatory Strategies: Insights into adaptive trial designs, real-world evidence (RWE), and navigating evolving FDA/China NMPA frameworks.
- Digital Transformation: The role of big data, blockchain, and automation in R&D and supply chain optimization.
- Market Access & Investment: Trends in global pricing, reimbursement models, and funding for innovative startups.

Program Highlights
BIOPH CHINA 2026 will feature a dynamic agenda blending scientific rigor with practical applications:
- Keynote Presentations: Visionary talks from Nobel laureates, CEOs of leading biopharma companies (e.g., Pfizer, Moderna, Sinopharm), and pioneers in CRISPR and immunotherapy.
- Thematic Tracks: Parallel sessions covering oncology, neurology, rare diseases, and infectious disease therapeutics.
- Innovation Showcase: A dedicated exhibition area where 300+ companies will present breakthrough technologies, from lab automation to novel drug delivery systems.
- Workshops & Hackathons: Hands-on sessions on AI in drug screening, regulatory compliance, and startup incubation.
- Networking Forums: Structured matchmaking, CEO roundtables, and investor-pitch sessions fostering cross-border collaborations.

Why Shanghai?
As China’s biopharma hub, Shanghai offers unparalleled access to a $100+ billion market, world-class research institutions (e.g., Fudan University, Shanghai Institute of Materia Medica), and government-backed initiatives like the "14th Five-Year Plan" for biotechnology. The city’s infrastructure, multilingual talent pool, and proximity to Asia’s fast-growing healthcare ecosystem make it the ideal venue for global partnerships.

Call to Action
BIOPH CHINA 2026 is more than a conference—it’s a catalyst for change. Whether you’re seeking to launch a new therapy, optimize manufacturing, or secure strategic partnerships, this event provides the platform to drive innovation in an era of unprecedented scientific opportunity. Join us in Shanghai to shape the future of medicine.

For registration and program details, visit [www.biophchina.com](https://www.biophchina.com).